Revolutionary Medical Devices, Inc. began June 2013. Since inception, RMD has focused on developing innovative technologies to improve patient outcomes and increase efficiency with regards to airway management.
RMD has already received worldwide recognition from Key Opinion Leaders within airway management and anesthesia; its technologies are living up to their name, “Revolutionary”.
The company’s mission is to be the first choice for customers through innovation and dedication to quality.
RMD develops products for airway management, with the objective of significantly improving patient outcomes from anesthesia.© Its products are being designed to reduce life-threatening complications associated with airway management, expedite O.R. set up and turnover time, and help reduce the hospital’s overall cost per patient visit.
Anesthesiology 2017 (ASA)
OCT 21-25, 2017
The Post Graduate Assembly in Anesthesiology (PGA71)
NEW YORK, NY
DEC 8 -12, 2017
MEET THE RMD TEAM
Tucson, AZCorporate Office
IllinoisContracted Product Fulfillment
New YorkSales Region 1
New JerseyProduct Commercialization
and Sales Region 2
PennsylvaniaSales Region 2
New HampshireChief Medical Officer
and Sales Region 4
MaineSales Region 4
Delaware, Maryland, North VirginiaSales Region 3
Shenzhen, ChinaContracted Product Manufacturer
President & Chief Executive Officer
Mr. Kane, co-inventor, is an insightful, solutions-driven executive and change agent with 30+ years of experience driving operational excellence and exceeding profitability goals for start-up, high-growth, and mature operations. He is a visionary leader with entrepreneurial mindset; known for spearheading design, development, and launch of multimillion-dollar business units and S&T product innovations.
Michael Pedro, MD
Chief Medical Officer
Dr. Michael Pedro, co-inventor of the SuperNO2VA™, is an attending anesthesiologist who was frustrated seeing his patients suffer from intra-operative and post-operative respiratory compromise and made it his mission to develop a solution. Dr. Pedro also has years of clinical research experience and has been responsible for engaging anesthesia thought leaders to help develop the SuperNO2VA™ device’s long-range clinical strategy.
Chief Operating Officer
Mr. Thomas Reilly has demonstrated experience in manufacturing, product development, operations management, customer support, engineering management, and information technology management. Mr. Reilly’s experience ranges from private companies to publically traded companies; including DOD research, commercial supercomputing, biometrics, and movie special effects. Production and development of products ranges from building 10’s of multi-million dollar units to 10’s of thousands of low dollar units.
Vice President of Sales and Marketing
Having held sales leadership positions at both GE Healthcare and King Systems (Ambu), Ms. Kurilko brings over 14 years of medical device sales and marketing experience. Ms. Kurilko heads the RMD initiative for commercialization of new medical devices. She is responsible for the definition and implementation of the sales & marketing vision, strategy, and structure. Her areas of focus include sales force construction, sales operations, and personnel management for field sales and clinical services.
Paul Molloy, CEO at ClearFlow, is a serial entrepreneur and medical device industry veteran with twenty-five years experience of leading public, private and VC-funded healthcare companies. Currently he serves on the Board and Audit Committee at CAS Medical (NASDAQ, CASM) and Velano Vascular. Previously, he was a Board member at MiCardia, LMA and VasoNova. Before joining ClearFlow, Paul was CEO at VasoNova Inc.- a Silicon Valley based, venture-funded vascular navigation company acquired by Teleflex Inc. (NYSE, TFX), in January 2011. Following the acquisition, he was appointed President of Teleflex’ largest division – ARROW Vascular – having full P&L responsibilities for direct sales, US and overseas manufacturing plants, R&D and strategic planning at corporate level. Under his tenure VasoNova was successfully integrated under the ARROW Vascular brand. Prior to VasoNova, Paul was President and Managing Director of LMA, overseeing all European and Asian subsidiaries. Paul took LMA public in 2005 and later brokered its acquisition by Teleflex in 2012. Paul started his career as a practicing CRNA (Certified Registered Nurse Anesthetist) at Medical University Alkmaar in the Netherlands. In 1989 he joined Datascope Corp. where he progressed through successive sales and marketing roles with growing responsibilities. He has extensive global industry connections and is well-versed in setting up and managing international operations. He has traveled, lived and worked in Europe, Asia and the USA and is fluent in German, Dutch and English. Paul holds an MBA from the University of Chicago’s Booth School of Business.
Nick Soloway, RMD’s patent attorney, is one of 200 practicing patent attorneys in the United States to be included in Woodward/White’s Best Lawyers in America. Mr. Soloway has been practicing in the intellectual property profession for over 40 years. Mr. Soloway has filed and prosecuted well over 10,000 patents and trademarks for large and small corporations in the United States and throughout the world and his client base includes industry leaders in aerospace, biotechnology, pharmaceuticals, chemical technologies, mechanical and electromechanical technologies and microelectronics. Nick is also a serial entrepreneur, and has started and managed numerous technology companies, including several in the medical device field.
Dr. Bryan L. Walser, MD, JD served as the Chief Executive Officer at Allergen Research Corporation. Dr. Walser served as an Interim Chief Executive Officer of Perlegen Sciences, Inc. since May 1, 2007. He has overall responsibility for management of Perlegen Sciences, Inc.’s operations, organizational development and honing Perlegen’s strategic mission. Dr. Walser served as Chief Executive Officer of Perlegen Sciences, Inc. Dr. Walser served as the Vice President, Corporate Strategy and Corporate Affairs for Chiron Corporation in Emeryville, California since November 2001. Before that, he was a principal with WRW Advisors in Los Angeles, California, and an emergency room physician at UCLA. Prior to joining Chiron, Dr. Walser was an independent management consultant, working with The Rockefeller Foundation and the Boston Consulting Group. Dr. Walser also spent five years with The Boston Consulting Group’s healthcare practice, based in Los Angeles. He serves as a Director of GeneFluidics, Inc. He served as a Director of Perlegen Sciences, Inc. He has published a number of peer-reviewed articles on topics ranging from renal physiology and tropical medicine to international regulatory policy. He is an International Health Policy Fellow in Basel, Switzerland of F.Hoffmann-La Roche AG. Dr. Walser trained in the Emergency Medicine program at UCLA. He was a Fulbright Fellow in Indonesia, and conducted biomedical and epidemiological research in the favelas of northeastern Brazil. He holds a BS in Biology and an Undergraduate Degree from Stanford University. Dr. Walser earned his Medical Degree from the University of Virginia School of Medicine and his Law Degree, magna cum laude, from Harvard Law School.
Myron J. Fox, president MJF Health, Inc., has spent more than two decades providing clinical sales, consulting & relationship expertise between major healthcare institutions & medical device manufacturers and its distributors, from startups through Fortune 500. Mr. Fox maintains a successful sales record of diagnostic & therapeutic capital equipment & disposable medical surgical devices and a history of award winning high quality measurable results, experience spans diverse assignments within consumer, healthcare and institutional healthcare markets, supporting; Anesthesiologist, Administrators, Critical Care, Emergency Medicine, Gastroenterologist, Interventional Radiologist, and other clinicians.
Jerry Vance is the founder and managing partner of Preferred CFO. He has provided CFO consulting services for over 300 businesses in various industries over the last 13 years. He has prepared hundreds of forecasts and has assisted hundreds of companies through the fundraising process. He specializes in management consulting, acquisition, fundraising, forecasting, valuation, equity, debt and other accounting services. Jerry has been instrumental in securing and accounting for hundreds of millions of dollars of debt and or equity transactions. Prior to providing consulting services, Jerry served multiple public and private companies as a CFO and/or controller, some with international subsidiaries. He is a graduate of the University of Utah and currently serves as CFO of the Wayne Brown Institute. He enjoys serving as a mentor to many early stage companies and is an active angel investor.
MEDICAL ADVISORY BOARD
Roger S. Mecca, M.D.
Dr. Roger Mecca is an Anesthesiologist, subspecialized in Critical Care, with special expertise in Respiratory Physiology, Postoperative Care, and Complications of Anesthesia and Surgery.
A graduate of the Massachusetts General / Harvard Anesthesiology residency, Dr. Mecca is affiliated with the University of California in Irvine as a Clinical Professor of Anesthesiology. His past experience includes service as Vice President for Medical Affairs at a division of Covidien and as Chairman of Anesthesiology at Danbury Health Systems.
Dr. Mecca also has extensive experience in professional publication, medical device development, and hyperbaric / aerospace medicine.
Jessica Feinleib, M.D., Ph.D.
Jessica Feinleib, M.D., Ph.D., is Assistant Professor of Anesthesiology at the Yale School of Medicine and Staff Anesthesiologist VACTHS.
Dr. Feinleib is the subject matter expert for the National Veteran’s Administration Difficult Airway Algorithm and Rescue Circothyrotomy (DAARC) simulation program. She is a member of the Society for Airway Management MedicAlert Task Force and has written several text book chapters on airway management, including chapters in KJ Lee’s Otolaryngology and Rosenblatt and Popescu’sMaster Techniques in Upper and Lower Airway Management. Recently, she has written on Difficult Airway Communications, Database Registries, and Reporting Systems Registries in Anesthesia Clinics.
Dr. Feinleib is the medical director for the VACTHS Simulation Program and a certified healthcare simulation educator (CHSE). She has been providing novel airway instruction through simulation nationally.
Lorraine J. Foley, MD, MBA
Dr. Foley is presently the Vice President of the Society of Airway management as well as one of the founding members of the Society. She is also Co-chair of the Difficult Airway Registry and Medic Alert and was the first recipient of the Distinguished Service award in 2006 from the Society of Airway Management. Dr. Foley also was the inventor of the FAST (Foley Airway Stylet Tool) by Clarus Medical.
Dr. Foley did her anesthesiology residency at Beth Israel Hospital, Harvard Medical School in Boston where she remained on staff as an anesthesiologist and instructor of anesthesia for Harvard Medical School for six years. At present she is a Staff Anesthesiologist at Winchester Hospital and Clinical Assistant Professor of Anesthesia, Tufts School of Medicine in Boston. Dr. Foley recently received her MBA from Northeastern University, Boston, MA and has multiple publications and chapters in textbooks.
Revolutionary Medical Devices, Inc.
6363 N. Swan Rd. Suite 200
Tucson, AZ 85718